DJ‑1 is a new prognostic marker and predicts chemotherapy efficacy in colorectal cancer-Reference-Cited by-同舟云学术

DJ‑1 is a new prognostic marker and predicts chemotherapy efficacy in colorectal cancer

Published:2020-04-23 Issue:1 Volume:44 Page:77-90
ISSN:1021-335X
Container-title:Oncology Reports
language:
Short-container-title:Oncol Rep

Author:

Wang Weimin¹,Wang Haibo¹,Xiang Liangliang²,Ni Tengyang²,Jin Feng²,Deng Jianliang¹,Zhang Yunlei¹,Shintaro Ishikawa³,Zhou Yan¹,Liu Yanqing¹

Affiliation:

1. Department of Oncology, Yixing Hospital Affiliated to the Medical College of Yangzhou University, Yangzhou University, Yixing, Jiangsu 214200, P.R. China

2. Institute of Combination of Chinese Traditional and Western Medicine, Medical College, Yangzhou University, Yangzhou, Jiangsu 225000, P.R. China

3. Department of Physiology, School of Medicine, Showa University, Shinagawa‑ku, Tokyo 142‑8555, Japan

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology,General Medicine

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development of Inhibitors, Probes, and PROTAC Provides a Complete Toolbox to Study PARK7 in the Living Cell;Journal of Medicinal Chemistry;2024-05-07

2. Diallyl disulfide antagonizes DJ‐1 mediated proliferation, epithelial–mesenchymal transition, and chemoresistance in gastric cancer cells;Environmental Toxicology;2024-04-20

3. Clinical value of serum DJ-1 in lung adenocarcinoma;PeerJ;2024-01-29

4. DJ-1: A Potential Biomarker Related to Prognosis, Chemoresistance, and Expression of Microenvironmental Chemokine in HR-Positive Breast Cancer;Journal of Immunology Research;2023-12-13

5. First-line treatment with TKI plus brain radiotherapy versus TKI alone in EGFR-mutated non-small cell Lung cancer with brain metastases: a systematic review and meta-analysis;BMC Cancer;2023-10-30